Logo

American Heart Association

  2
  0


Final ID:

Renoprotection Drives Cardioprotection in Heart Failure

  • Lefer, David  ( Cedars-Sinai Medical Center , Los Angeles , California , United States )
  • Author Disclosures:
    David Lefer: DO have relevant financial relationships ; Consultant:Gordian Biotechnology:Active (exists now) ; Consultant:Sulfagenix:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Systemic Approach for Heart Failure

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts from these authors:
Hydrogen Sulfide and HFpEF

Lefer David

Weight Loss Independent Benefits of the GLP-1 Receptor Agonist Semaglutide in Cardiometabolic HFpEF

Elbatreek Mahmoud, Li Zhen, Yu Xiaoman, Arkat Silpa, Shah Sanjiv, Goodchild Traci, Lefer David

You have to be authorized to contact abstract author. Please, Login
Not Available